• Health & Medicine

Breast cancer drug currently too expensive for NHS

NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS

29 December 2016

• Health & Medicine
• Science & Technology

7 tweets that defined cancer policy in 2016

We pick out 7 top stories from the world of cancer policy and politics that defined 2016. We pick out 7 top stories from the world of cancer policy and politics that defined 2016.

22 December 2016

• Health & Medicine

The cancer registry is saving lives, but you’ve probably never heard of it

The UK’s data on cancer leads the world, and we should be telling people about that. The UK’s data on cancer leads the world, and we should be telling people about that.

20 December 2016

• Health & Medicine

Plans for £200m NHS England cancer investment announced

Spending plans for new investment in NHS radiotherapy machines and £200m to improve local cancer services in England have been announced. Spending plans for new investment in NHS radiotherapy machines and £200m to improve local cancer services in England have been announced.

7 December 2016

• Health & Medicine

International Day of Radiology: A day in the life of a breast imaging radiologist

For International Day of Radiology we caught up with Dr Nisha Sharma, a breast imaging radiologist, to shed some light on what radiology is all about. For International Day of Radiology we caught up with Dr Nisha Sharma, a breast imaging radiologist, to shed some light on what radiology is all about.

8 November 2016

• Health & Medicine

Radiotherapy gets the investment it needs

NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important. NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important.

25 October 2016

• Health & Medicine

Cancer waiting times: what's causing the delays?

A key cancer waiting time target has been missed again in England, we investigate why. A key cancer waiting time target has been missed again in England, we investigate why.

13 October 2016

• Health & Medicine

More people are getting cancer, but what do the numbers really mean?

New figures we’ve released today estimate that by the year 2035, half a million people could be diagnosed with cancer each year in the UK. New figures we’ve released today estimate that by the year 2035, half a million people could be diagnosed with cancer each year in the UK.

12 October 2016

• Health & Medicine

Our Local Cancer Statistics website – three years on

We explore how local data is shaping cancer services in your area. We explore how local data is shaping cancer services in your area.

3 October 2016

• Health & Medicine

Improving care for cancer patients in Northern Ireland

Our new report looking at cancer care in Northern Ireland uncovers some key areas for improvement. Our new report looking at cancer care in Northern Ireland uncovers some key areas for improvement.

7 September 2016

• Health & Medicine

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England. Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

31 August 2016

• Health & Medicine
• Science & Technology

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why. Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

17 August 2016